Dow Up 0.76% Nasdaq Up 0.69%

CytRx Corporation (CYTR)

-NasdaqCM
2.80 Down 0.11(3.78%) Oct 24, 3:59PM EDT
Prev Close:2.91
Open:2.88
Bid:2.83 x 1100
Ask:3.02 x 1000
1y Target Est:11.00
Beta:0.86
Next Earnings Date:N/A
Day's Range:2.75 - 2.98
52wk Range:2.00 - 8.35
Volume:817,822
Avg Vol (3m):831,486
Market Cap:156.10M
P/E (ttm):N/A
EPS (ttm):-1.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTR

Comparison

Symbol% ChgMkt Cap
CYTRDown 3.78%156.10M
LLYUp 2.64%70.79B
NVSUp 1.02%218.72B
SNYUp 0.92%141.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,622.33
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.70
Quarterly EPS Est (Sep-14) :-0.25
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate includes aldoxorubicin that has completed Phase IIb clinical trial as a first-line therapy for soft t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback